Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

But people with diabetes or morbid obesity may weigh their risks and benefits differently, and may be more willing to accept hair loss as a potential risk, the researchers added. One of the ...

This article discusses morbid obesity and BMI, the risks associated with morbid obesity, how to treat morbid obesity, and getting support for recovery. Body mass index is considered a dated and flawed ...

In preclinical models, researchers identified a key molecular mechanism by which stress and obesity trigger changes in pancreatic cells that may lead to cancer. Specifically, stress-related ...

H.C. Wainwright says Novo Nordisk’s (NVO) REDEFINE-2 results reinforce Viking Therapeutics’ (VKTX) VK2735’s potential in obesity and beyond. Assuming full adherence, Novo’s CagriSema ...

Mar. 3, 2025 — Obesity rates are set to skyrocket, with one in six children and adolescents worldwide forecast to be obese by 2050, according to a new study. But with significant increases ...

The trial included 1,206 randomized people with obesity or overweight and type 2 diabetes and a mean baseline body weight of 102 kg. The trial achieved its primary endpoint by demonstrating a ...

Human GWAS paradoxically linked FTO SNPs to both lean mass and sarcopenia/obesity. Here, Guang et al used CRISPR-edited stem cells to reveal that an obesogenic FTO SNP accelerates both muscle ...